Enovix Co. (NASDAQ:ENVX) Short Interest Up 13.9% in April

Enovix Co. (NASDAQ:ENVXGet Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 41,800,000 shares, a growth of 13.9% from the March 31st total of 36,690,000 shares. Currently, 30.6% of the shares of the stock are short sold. Based on an average trading volume of 4,360,000 shares, the days-to-cover ratio is presently 9.6 days.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $30.00 price target on shares of Enovix in a research report on Thursday. JPMorgan Chase & Co. decreased their target price on Enovix from $18.00 to $12.00 and set an “overweight” rating on the stock in a research report on Friday. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price target on shares of Enovix in a research report on Wednesday, February 21st. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $27.43.

View Our Latest Analysis on Enovix

Enovix Price Performance

NASDAQ:ENVX traded up $0.03 during trading hours on Monday, reaching $6.49. 5,280,244 shares of the company traded hands, compared to its average volume of 4,417,842. Enovix has a 1-year low of $5.70 and a 1-year high of $23.90. The stock has a market cap of $1.09 billion, a P/E ratio of -4.24 and a beta of 1.62. The firm’s 50-day moving average is $8.07 and its 200-day moving average is $10.07. The company has a debt-to-equity ratio of 0.65, a current ratio of 5.30 and a quick ratio of 5.15.

Enovix (NASDAQ:ENVXGet Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.01). The company had revenue of $7.38 million for the quarter, compared to analyst estimates of $3.37 million. Enovix had a negative net margin of 2,800.51% and a negative return on equity of 77.74%. Equities research analysts expect that Enovix will post -1.13 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Enovix news, COO Ajay Marathe sold 4,954 shares of the business’s stock in a transaction on Sunday, April 14th. The shares were sold at an average price of $7.31, for a total transaction of $36,213.74. Following the sale, the chief operating officer now directly owns 978,913 shares in the company, valued at approximately $7,155,854.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 17.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Enovix

A number of hedge funds and other institutional investors have recently modified their holdings of ENVX. Beacon Capital Management LLC increased its stake in Enovix by 66.7% in the fourth quarter. Beacon Capital Management LLC now owns 2,500 shares of the company’s stock valued at $31,000 after purchasing an additional 1,000 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of Enovix during the 3rd quarter valued at about $31,000. Carmel Capital Partners LLC purchased a new position in shares of Enovix during the 3rd quarter worth about $34,000. Able Wealth Management LLC acquired a new stake in shares of Enovix in the fourth quarter worth approximately $34,000. Finally, Quest Partners LLC purchased a new stake in Enovix in the fourth quarter valued at approximately $49,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.